Clinical trial
The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
NCT00187408 · Sunnybrook Health Sciences Centre, Other · Completed
Key facts
| NCT number | NCT00187408 |
|---|---|
| Title | The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial |
| Official title | Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention |
| Lead sponsor | Sunnybrook Health Sciences Centre, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Low Molecular Weight Heparin (dalteparin) |
| Enrollment | 700 |
| Start date | Aug 1, 2002 |
| Completion | Jan 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 27, 2007 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: